期刊文献+

促性腺激素释放激素激动剂联合低剂量绒促性激素激发排卵的临床效果 被引量:2

Clinical effects of dual trigger on oocyte maturation w ith gonadotropinreleasing hormone agonist and low-dose human chorionic gonadotropin
原文传递
导出
摘要 目的探讨促性腺激素释放激素拮抗剂(GnRHant)方案中使用促性腺激素释放激素激动剂(GnRHa)联合低剂量绒促性激素(hCG)激发排卵的临床效果。方法回顾性分析270个GnRHant方案中卵巢反应正常、行新鲜胚胎移植患者的临床资料,根据激发排卵的药物将患者分为3组:hCG组、GnRHa联合低剂量hCG组、GnRHa组。观察3组的获卵数、妊娠率、流产率和卵巢过度刺激综合征(OHSS)的发生情况。结果在3组激发排卵日大卵泡数相近的情况下,GnRHa联合低剂量hCG组的获卵数显著增加。hCG组、GnRHa联合低剂量hCG组、GnRHa组的临床妊娠率分别为41.72%、59.49%、40.00%;胚胎种植率分别为23.53%、35.43%、23.40%,组间差异均有统计学意义(P<0.05);3组流产率的差异无统计学意义(P>0.05)。仅hCG组有1例轻度OHSS发生。结论 GnRHa联合低剂量hCG激发排卵能增加获卵数,改善胚胎种植率,提高妊娠率。 Objective To investigate the clinical effect of dual trigger with gonadotropin-releasing hormone agonist (GnRHa) and low-dose human chorionic gonadotropin (hCG) on oocyte maturation for normal responders. Methods Complete clinical data of 270 in vitro fertilization and embryo transfer(IVF-ET) cycles from normal responder patients with a GnRH antagonist-based ovarian stimulation protocol who were transferred with fresh embryos were retrospectively analyzed. The patients were divided into three groups based on trigger protocols: hCG group, GnRHa and low-dose hCG group,GnRHa group. The retrieved oocytes, clinical pregnancy rates, implantation and ovarian hyperstimulation syndrome (OHSS) were compared. Results The retrieved oocytes in GnRHa and low-dose hCG group significantly increased compared with the other two groups even though the number of large follicles on trigger day were similar. Clinical pregnancy rates of hCG group, GnRHa and low-dose hCG group and GnRHa group were 41.72%, 59.49% and 40.00%, respectively, which were significantly different( all P 〈 0.05 ). The implantation rates of hCG group, GnRHa and low-dose hCG group and GnRHa group were 23.53%, 35.43% and 23.40%, respectively, which were also significantly different(all P 〈0.05). The miscarriage rates among the three groups were similar(P 〉0.05). Only one woman with pregnancy in hCG group developed mild OHSS. Conclusion Dual trigger of oocyte maturation with GnRHa and low-dose hCG in normal responders can increase retrieved oocytes and improve implantation rate and pregnancy rate.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第3期64-67,71,共5页 Journal of Shandong University:Health Sciences
关键词 促性腺激素释放激素拮抗剂 促性腺激素释放激素激动剂 绒促性激素 激发排卵 妊娠率 Gonadotropin-releasing hormone antagonist Gonadotropin-releasing hormone agonist Human chorionic gonadotropin Ovulation trigger Pregnancy rate
  • 相关文献

参考文献13

  • 1Iliodromiti S, Blockeel C, Tremellen K P, et al. Consist- ent high clinical pregnancy rates and low ovarian hypers- timulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retro- spective multicenter study[ J]. Hum Reprod, 2013, 28 (9) .2529-2536. 被引量:1
  • 2Humaidan P, Polyzos N P, Alsbjerg B, et al. GnRHa trigger and individualized luteal phase hCG support ac- cording to ovarian response to stimulation: two prospec- tive randomized controlled multi-centre studies in IVF pa- tients [ J ]. Hum Reprod, 2013, 28 (9) : 2511-2521. 被引量:1
  • 3Humaidan P. Luteal phase rescue in high-risk OHSS pa- tients by GnRHa triggering in combination with low-dose HCG: a pilot study [ J ]. Reprod Biomed Online, 2009, 18 ( 5 ) :630-634. 被引量:1
  • 4Youssef M A, Van der Veen F, Al-Inany H G, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive tech- nology cycles [ J ]. Cochrane Database Syst Rev, 2011, 19( 1 ) :CD008046. doi: 10.1002/14651858. 被引量:1
  • 5Griffin D, Benadiva C, Kummer N, et al. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to op- timize live birth rates in high responders [J]- Fertil Steril, 2012, 97(6) :1316-1320. 被引量:1
  • 6Lin M H, Shao-Ying Wu F, Kuo-Kuang Lee R, et al. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin signif- icantly improves the live-birth rate for normal responders in GnRH-antagonist cycles E Jl. Fertil Steril, 2013, 100 (5) : 1296-1302. 被引量:1
  • 7鹿群,沈浣,王丛,郑兴邦,陈曦,梁蓉,魏丽惠.脱氢表雄酮对卵巢反应不良患者体外受精-胚胎移植的影响[J].山东大学学报(医学版),2013,51(2):84-87. 被引量:7
  • 8Broekmans F J, Kwee J, Hendriks D J, et al. A system- atic review of tests predicting ovarian reserve and IVF out- come[J]. Hum Reprod Update, 2006, 12(6) :685-718. 被引量:1
  • 9Fatemi H M, Polyzos N P, van Vaerenbergh I, et al. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hor- mone-gonadotropin-releasing hormone antagonist in vitrofertilization cycles [J]. Fertil Steril, 2013, 100 ( 3 ) : 742- 747. 被引量:1
  • 10Kol S, Humaidan P, Itskovitz-Eldor J. GnRH agonist ovulation trigger and hCG-based, progesterone-free lute- al support: a proof of concept study [J]. Hum Reprod, 2011, 26(10) :2874-2877. 被引量:1

二级参考文献15

  • 1Gleicher N, Barad D H. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR) [ J]. Reorod Biol Endocrinol. 2011. 9:67-79. 被引量:1
  • 2Weghofer A, Kim A, Barad D H, et al. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation[J ]. Hum Reprod, 2012, 27( 11 ) :3287- 3293. 被引量:1
  • 3Barad D, Brill H, Gleicher N. Update on the use of de- hydroepiandrosterone supplementation among women with diminished ovarian function [ J ]. J Assist Reprod Genet, 2007, 24 (12) :629-634. 被引量:1
  • 4Gleicher N, Kim A, Weghofer A, et al. Starting and re- sulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnan- cy rates in women with diminished ovarian reserve (DOR) [J ]. J Assist Reprod Genet, 2012. E Epub ahead of print 1. 被引量:1
  • 5Gleicher N, Weghofer A, Barad D H. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation[J ]. Reprod Biomed Online, 2010, 21 (3) :360-365. 被引量:1
  • 6Gleicher N, Weghofer A, Barad D H. Dehydroepiandros- terone (DHEA) reduces embryo aneuploidy: direct evi- dence from preimplantation genetic screening (PGS) [J ]. Reprod Biol Endocrinol, 2010, 8 : 140-145. 被引量:1
  • 7Gleicher N, Ryan E, Weghofer A, et al. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementa- tion in women with diminished ovarian reserve: a case control study[J ]. Reprod Biol Endocrinol, 2009, 7 : 108- 115. 被引量:1
  • 8Wiser A, Gonen O, Ghetler Y, et al. Addition of de- hydroepiandrosterone (DHEA) for poor-responder pa- tients before and during IVF treatment improves the preg- nancy rate: a randomized prospective study [J ]. Hum Re- prod, 2010, 25(10):2496-2500. 被引量:1
  • 93osdou J K, Venetis C A, Kolibianakis E M, et al. The se of androgens or androgen-modulating agents in poor "esponders undergoing in vitro fertilization: a systematic -eview and meta-analysis [J ]. Hum Reprod Update, .012, 18(2) :127-145. 被引量:1
  • 10Ferraretti A P, La Marca A, Fauser B C, et al. ESHRE consensus on the definition of ' poor response' to ovari-an stimulation for in vitro fertilization: the Bologna crite- ria[J ]. Hum Reprod, 2011, 26(7) :1616-1624. 被引量:1

共引文献6

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部